The latest drugs in development that reduce intraocular pressure in ocular hypertension and glaucoma

V Jayanetti, S Sandhu, JA Lusthaus - Journal of Experimental …, 2020 - Taylor & Francis
… -lowering therapies and then outlines pipeline ocular hypotensive agents, their mechanisms
… new drug classes, such as tyrosine protein kinase activators. Most developing drugs are …

Topical medication therapy for glaucoma and ocular hypertension

T Wang, L Cao, Q Jiang, T Zhang - Frontiers in Pharmacology, 2021 - frontiersin.org
… Comparing to eye drops containing preservatives, preserver free medicines can better
decrease the incidence of ocular side effects and increase ocular comfortable. So, it is necessary …

Current situation and progress of drugs for reducing intraocular pressure

P Liu, F Wang, Y Song, M Wang… - … advances in chronic …, 2022 - journals.sagepub.com
… According to the latest clinical guidelines for glaucoma, the … drug that is primarily used
for the treatment of ocular … dextrose induced ocular hypertension in rats OHT, glaucoma …

Absorption enhancement strategies in chitosan-based nanosystems and hydrogels intended for ocular delivery: Latest advances for optimization of drug permeation

I Dmour - Carbohydrate Polymers, 2024 - Elsevier
… , including immunomodulating agents, antibiotics, ocular hypertension medications, etc. CS-…
ocular diseases by penetrating biological ocular barriers and targeting and controlling drug

Topical Ripasudil as First Line Treatment for Ocular Hypertension in Uveitis Cases: An Analytic Study.

H Nagpal, M KAUR - Journal of Clinical & Diagnostic …, 2021 - search.ebscohost.com
… other IOP lowering drugs in uveitis cases. In this study, role of ripasudil as first line drug to
lower … All the cases were classified in accordance to latest definitions by International Uveitis …

Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study

DR Anderson - JAMA ophthalmology, 2021 - jamanetwork.com
… years ago in the Ocular Hypertension Treatment Study (OHTS… started treatment when ocular
hypertension was discovered … Does this mean that patients with ocular hypertension might …

Efficacy and patient tolerability of omidenepag isopropyl in the treatment of glaucoma and ocular hypertension

M Matsuo, Y Matsuoka, M Tanito - Clinical Ophthalmology, 2022 - Taylor & Francis
… Most ocular AEs were considered to be causally related to the study drug, and less frequently
reported non-ocular … provided information on the status of latest clinical trials of OMDI and …

Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension

S Sinha, D Lee, NN Kolomeyer, JS Myers… - Expert Opinion on …, 2020 - Taylor & Francis
… Latanoprost, a common first line drug used for … latest glaucoma eye drops marketed for the
reduction of elevated IOP in patients with open-angle glaucoma (OAG) or ocular hypertension

[HTML][HTML] Efficacy of ripasudil in reducing intraocular pressure and medication score for ocular hypertension with inflammation and corticosteroid

R Yanai, SH Uchi, M Kobayashi, T Nagai… - International Journal …, 2023 - ncbi.nlm.nih.gov
… of anti-glaucoma drugs in patients with ocular hypertension with inflammation and corticosteroid.
… based on the latest recommendations from the International Uveitis Study Group [13] . …

High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis

T Ma, JL Sims, S Bennett, S Chew… - British journal of …, 2022 - bjo.bmj.com
ocular hypertension seen in Auckland uveitis clinics over the last 10 years. Results A total of
188 eyes of 139 subjects with uveitic glaucoma or ocular hypertensionocular hypertension